Introduction
Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and is an independent risk factor for cardiovascular disease (CVD) [1] . Pulmonary hypertension (PHT) is a common co-morbidity in patients with CKD and end-stage renal disease (ESRD) [2] . PH is associated with increased risk of hospitalization and mortality in patients with CKD [3] .Several studies demonstrated that PH is an independent predictor of mortality in patients with CKD, especially those receiving renal replacement therapy (RRT) [4] .Coexisting left side heart disease, chronic lung disease, thromboembolic disease, autoimmune diseases and liver disease that are well-established risk factors for developing PH may occur in patients with CKD. However, CKD especially ESRD by itself proposed to cause pulmonary vascular remodeling and PH. Possible mechanisms that have been suggested include endothelial dysfunction due to( increased oxidative stress from uremic toxins, chronic inflammation resulting from exposure of the blood to dialysis membrane), vascular calcification, and increased flow from arteriovenous fistula (AVF) [5] . Early diagnosis and early treatment of PH might improve the long-term outcomes. Therefore, it is crucial to investigate the epidemiology of PH before patients with CKD progress to ESRD [6] .
Patients and Methods
A cross sectional study was conducted on 124 patients with CKD who were maintained on long term regular hemodialysis therapy three times per week in 4-h sessions in hemodialysis unit in Sohag University Hospital. Ethics committee approval and informed consent were obtained . 
Exclusion criteria

Results of the study
Data on the 61(out of 124) patients with PH were compared with the 63 patients without PH in the hemodialysis patients. Diabetes mellitus and hypertension were the most common etiologies of renal failure in both subgroups. Brachial AVF; 43 out of 61 patients (70.5%) represent the majority of patients in PH subgroup, and radial AVF; 43 out of 63 (68.3%) represent the majority of patients in normal PAP subgroup of hemodialysis patients. There was a highly statistically significant increase in age, duration of dialysis treatment, serum phosphorous, serum parathyroid hormone and highly statistically significant decrease in serum calcium, HB level, Hematocrit % in PH subgroup compared to normal PAP subgroup. There is no statistically significant difference between both subgroups regarding ejection fraction. There is a highly statistically significant difference between both subgroups regarding RVH which demonstrated among 45 patients (73.8%) in PH subgroup comparing to 14 patients (22.2%) without PH subgroup . LVH which demonstrated among 40 patients (65.6%) in PH subgroup comparing to 21 patients (33.3%) without PH subgroup, left atrial diameter, LVEDD, LVESD were higher in patients with PH subgroup comparing patients without PH subgroup. Valvular calcification was demonstrated among 21 patients (34.4%) in PH subgroup comparing to 3 patients (4.8%) without PH subgroup with Statistically significant difference (p-value˂ 0.001). Diastolic dysfunction was demonstrated among 40 patients (65.6%) with PH subgroup comparing to 19 patients (30.2%) without PH subgroup with highly statistically difference between both subgroups.(p-value < 0.001) .
. (2006 ) reported that there was no significant difference between patients with PH and those without PH as regards to duration of dialysis. In this study there are 43 out of 61 patients (70.5%) with brachial AVF location had PH, in contrast to 18 patients (29.5%) with radial AVF location had PH among hemodialysis patients, which was a highly statistically significant difference (p < 0.001) .Also, Magdy et al ., (2013) reported that Brachial AVF; 23 out of 27 patients (85.18%) represent the majority of patients in the PH subgroup, and radial AVF; 23 out of 38 (60.52%) represent the majority of patients in the normal PAP subgroup of HD patients in his study . Fistula that is created in a large vessel has higher AVF blood flow, higher COP, increased sympathetic activity resulting in an increase in myocardial contractility and heart rate, increased pulmonary blood flow. On the other hand, Tarrass • No information about volume status or body composition analysis by bio impedance was collected. Conclusion § PH is a common finding in CKD patients; the prevalence was highest among patients with ESRD receiving long-term hemodialysis than those on conservative management. § Early detection of PH is important in order to avoid the serious consequences of the disease.
